Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment

Endocrinology

Volumn 139, Issue 5, 1998, Pages 2329-2334

  Uemura, Hiroji ^a   Chang, Chawnshang ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CALCIMYCIN; ETOPOSIDE; METRIBOLONE; STEROID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CASTRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VENTRAL LOBE; RAT;

EID: 0031734084     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.5.5969     Document Type: Article

References (41)

1. English HF, Kyprianou N, Isaacs JT 1989 Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 15:233-250
2. Kyprianou N, Isaacs JT 1988 Activation of programmed cell ceath in the rat ventral prostate after castration. Endocrinology 122:552-562
3. Martikainen P, Isaacs JT 1990 Role of calcium in the programmed death of rat prostatic glandular cells. Prostate 17:175-187
4. Buttyan R, Zakeri Z, Lockshin R, Wolgenuth D 1988 Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 2:650-657
5. Buttyan R, Olsson CA, Pintar J, Chang C, Bandy KM, Ng PY, Sawczuk IS 1989 Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9:3473-3481
6. Bettuzzi S, Troiano L, Davalli P, Tropea F, Ingletti MC, Grassilli E, Monti D, Corti A, Franceschi C 1991 In vivo accumulation of sulfated glycoprotein 2 mRNA in rat thymocytes upon dexamethasone-induced death. Biochem Biophys Res Commun 175:810-815
7. Kyprianou N, English HF, Davidson NE, Isaacs JT 1991 Programmed cell death during regression of the MCF-7 human breast cancer following androgen ablation. Cancer Res 51:162-166
8. Rennie PS, Bruchovsky N, Buttyan R, Benson M, Cheng H 1988 Gene expression during the early phases of regression of androgen-dependent Shionogi mouse mammary carcinoma. Cancer Res 48:6309-6312
9. Kyprianou N, English HF, Isaacs JT 1990 Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50:3748-3753
10. McDonell TJ, Troncoso P, Brisbay SM, Logothesis C, Chung LW, Hsieh JT, Tu SM, Campbell ML 1992 Expression of the protooncogene bd-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944
11. Kyprianou N, Isaacs JT 1988 Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123:2124-2131
12. McKeehan WL, Adams PS 1988 Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro Cell Dev Biol 24:243-246
13. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 13:103-118
14. Martikainen P, Kyprianou N, Tucker RW, Isaacs JT 1991 Programmed death of nonproliferating androgen-independent prostatic cancer cells. Cancer Res 51:4693-4700
15. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR 1992 Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214
16. Collotta F, Polentaratti N, Sironi M, Mantovani A 1992 Expression and involvement of c-fos and C-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267:18278-18283
17. Liu ZG, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA 1994 Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-284
18. Woronicz JD, Calnan B, Ngo V, Winoto A 1994 Requirement for the orphan steroid receptor nur77. Nature 367:277-281
19. Chang C, Kokontis T, Liao S, Chang Y 1989 Isolation and characterization of human TR3 receptor: a member of steroid receptor superfamily. J Steroid Biochem 34:391-395
20. Hazel T, Nathans D, Lau L 1988 A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA 85:8444-8448
21. Ryseck RP, MacDonald BH, Mattel M, Ruppert S, Bravo R 1989 Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor. EMBO J 8:3327-3335
22. Milbrandt J 1988 Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1:183-188
23. Watson MA, Milbrandt J 1989 The NGF1-B gene, a transcriptionally inducible member of the steroid receptor gene superfamily: genomic structure and expression in rat brain after seizure induction. Mol Cell Biol 9:4213-4219
24. Chang C, Saltzman A, Lee HJ, Uemura H, Chodak G, Nakamoto T, LeBeau M, Lemens RS, Sivak L, Shih C 1993 Genomic structure, chromosomal localization and expression of an androgen inducible TR3 orphan receptor: a member of the steroid receptor superfamily. Endocr J 1:541-549
25. Uemura H, Mizokami A, Chang C 1995 Identification of a new enhancer in the promoter region of human TR3 orphan receptor gene. J Biol Chem 270:5427-5433
26. Mizokami A, Yeh SY, Chang C 1994 Identification of 3′ 5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol Endocrinol 8:77-88
27. Sklar GN, Eddy HA, Jacobs SC,Kyprianou N 1993 Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. J Urol 150:1526-1532
28. Rennie PS, Bowden JF, Freeman SN, Bruchovsky N, Cheng H, Lubahn DB, Wilson EM, French FS, Main L 1989 Cortisol alters gene expression during involution of the rat ventral prostate. Mol Endocrinol 3:703-708
29. Wyllie AH 1980 Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556
30. Sellins KS, Cohen JJ 1987 Gene induction by gamma-irradation leads to DNA fragmentation in lymphocytes. Immunol 139:3199-3206
31. Wyllie AH, Morris RG, Smith AL, Dunlop D 1984 Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular systhesis. J Pathol 142:67-77
32. Kaczmarek L, Hyland JK, Watt R, Rosenberg M, Baserga R 1985 Microinjected c-myc as a competence factor. Science 228:1313-1315
33. Curran T, Franza BR 1988 Fos and Jun: the AP-1 connection. Cell 55:395-397
34. Quarmby VE, Beckman Jr WC, Wilson EM, French FS 1987 Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol Endocrinol 1:865-874
35. Katz AE, Benson MC, Wise GJ, Olsson CA, Bandyk MG, Sawczuk IS, Tomashesky P, Buttyan R 1989 Gene activity during the early phase of androgen-stimulated rat prostate regrowth. Cancer Res 49:5889-5894
36. Jenkins RB, Qian J, Lieber MM, Bostwick DG 1997 Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostaric carcinoma fluorescence in situ hybridization. Cancer Res 57:524-531
37. Rustgi AK, Dyson N, Bernards R 1991 Amino-terminal domains of c-Myc and N-Myc proteins mediate binding to the retinoblastoma gene product. Nature 352:541-544
38. Eisenberger MA, Simon R, O'Dwyer PJ 1985 A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma. J Clin Oncol 3:827-841
39. Pienta KJ, Redman B, Hussain M, Cummings G, Esper PS, Appel C, Flaherty LE 1994 Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. J Clin Oncol 12:2005-2012
40. Murphy GP, Slack NH, Mittelman A 1983 Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer. Semin Oncol [Suppl] 3:34-45
41. Scher HI, Sternberg C. Heston WD, Watson RC, Niedzwiecki D, Smart T, Hollander P, Yagoda A 1986 Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease. Cancer Chemother Pharmacol 18:24-26